ID   dH1f-RiPS-1.5
AC   CVCL_C702
DR   SKIP; SKIP000669
DR   SKIP; SKIP005175
DR   Wikidata; Q54831060
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
RX   PubMed=20888316; DOI=10.1016/j.stem.2010.08.012; PMCID=PMC3656821;
RA   Warren, Luigi
RA   Manos, Philip D.
RA   Ahfeldt, Tim
RA   Loh, Yuin-Han
RA   Li, Hu
RA   Lau, Frank
RA   Ebina, Wataru
RA   Mandal, Pankaj K.
RA   Smith, Zachary D.
RA   Meissner, Alexander
RA   Daley, George Quentin
RA   Brack, Andrew S.
RA   Collins, James Joseph
RA   Cowan, Chad A.
RA   Schlaeger, Thorsten M.
RA   Rossi, Derrick J.
RT   "Highly efficient reprogramming to pluripotency and directed
RT   differentiation of human cells with synthetic modified mRNA.";
RL   Cell Stem Cell 7:618-630(2010).
//